(Reuters) – Haleon reported a marginal fall in its third-quarter revenue on Thursday, hurt by declines in its pain relief and digestive health segments.
The British consumer healthcare group reported revenue of 2.78 billion pounds ($3.61 billion) for the three months ended Sept. 30, down from the 2.80 billion pounds posted last year.
($1 = 0.7711 pounds)
(Reporting by Yamini Kalia in Bengaluru; Editing by Sumana Nandy)
Comments